North Star Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63K | Hold |
13
| – | – | ﹤0.01% | 1107 |
|
|
2025
Q1 | $1.44K | Hold |
13
| – | – | ﹤0.01% | 1108 |
|
|
2024
Q4 | $1.77K | Hold |
13
| – | – | ﹤0.01% | 1124 |
|
|
2024
Q3 | $1.5K | Hold |
13
| – | – | ﹤0.01% | 1105 |
|
|
2024
Q2 | $1.79K | Hold |
13
| – | – | ﹤0.01% | 1046 |
|
|
2024
Q1 | $1.79K | Hold |
13
| – | – | ﹤0.01% | 1098 |
|
|
2023
Q4 | $1.71K | Hold |
13
| – | – | ﹤0.01% | 1060 |
|
|
2023
Q3 | $1.46K | Hold |
13
| – | – | ﹤0.01% | 1092 |
|
|
2023
Q2 | $1.23K | Hold |
13
| – | – | ﹤0.01% | 1130 |
|
|
2023
Q1 | $1.32K | Hold |
13
| – | – | ﹤0.01% | 1130 |
|
|
2022
Q4 | $1.55K | Hold |
13
| – | – | ﹤0.01% | 1112 |
|
|
2022
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 1085 |
|
|
2022
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 1089 |
|
|
2022
Q1 | $1K | Hold |
13
| – | – | ﹤0.01% | 1107 |
|
|
2021
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 1135 |
|
|
2021
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 1084 |
|
|
2021
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 1060 |
|
|
2021
Q1 | $1K | Hold |
13
| – | – | ﹤0.01% | 1023 |
|
|
2020
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 997 |
|
|
2020
Q3 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 978 |
|